Compare KOPN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOPN | OSUR |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.8M | 215.9M |
| IPO Year | 2025 | 2000 |
| Metric | KOPN | OSUR |
|---|---|---|
| Price | $5.08 | $2.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $4.69 | $3.00 |
| AVG Volume (30 Days) | ★ 11.6M | 509.3K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.03 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,530,311.00 | ★ $167,064,000.00 |
| Revenue This Year | $50.07 | $4.48 |
| Revenue Next Year | $33.33 | $7.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 46.53 | N/A |
| 52 Week Low | $1.23 | $2.08 |
| 52 Week High | $6.45 | $3.76 |
| Indicator | KOPN | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 47.23 |
| Support Level | $2.05 | $2.87 |
| Resistance Level | N/A | $3.24 |
| Average True Range (ATR) | 0.68 | 0.14 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 54.19 | 29.26 |
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.